AntineoplasticsLack of efficacy followed by off-label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1956卷 / 1期

关键词：

D O I：

10.1007/s40278-023-38677-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[31] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2021, 1886 (1) : 286 - 286
[32] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1896 (1) : 312 - 312
[33] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1906 (1) : 276 - 276
[34] Dexamethasone/remdesivirLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2023, 1973 (1) : 116 - 116
[35] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1905 (1) : 344 - 344
[36] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1932 (1) : 419 - 419
[37] ApremilastLack of efficacy during off-label use: 2 case reports
Reactions Weekly, 2023, 1950 (1) : 69 - 69
[38] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2022, 1934 (1) : 302 - 302
[39] Antiprotozoal/antibacterialsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2021, 1879 (1) : 51 - 51
[40] Multiple drugsLack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2021, 1842 (1) : 261 - 261

← 1 2 3 4 5 →